Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Oncology Letters|January 23, 2020
Evaluation of azacitidine in patients with transplant-ineligible myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes in a Japanese clinical settingAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 7, 2018
[Successful treatment with brentuximab vedotin maintenance therapy after autologous stem cell transplantation in high-risk Hodgkin lymphoma]Kazuyoshi Ishii, Yoshiko Azuma, Akiko Konishi, et al.
Transplantation and Cellular Therapy|May 14, 2021
Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell TransplantationMasaaki Hotta, Atsushi Satake, Hideaki Yoshimura, et al.
Transplant Immunology|November 1, 2019
Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantationShosaku Nomura, Akiko Konishi, Yukie Tsubokura, et al.
Hematology Reports|October 4, 2019
A variant of acute promyelocytic leukemia with t(4;17)(q12;q21) showed two different clinical symptomsTakahisa Nakanishi, Aya Nakaya, Yusuke Nishio, et al.
International Journal of Hematology|April 25, 2020
Comparison of starting doses of anagrelide as a first-line therapy in patients with cytoreductive therapy-naïve essential thrombocythemia: difference between starting at 0.5 and 1.0 mg/dayYoshinori Hashimoto, Tomoki Ito, Yasuhiro Tanaka, et al.
European Journal of Haematology|May 21, 2019
Efficacy and safety of anagrelide as a first-line drug in cytoreductive treatment-naïve essential thrombocythemia patients in a real-world settingTomoki Ito, Yoshinori Hashimoto, Yasuhiro Tanaka, et al.
Hematology (Amsterdam, Netherlands)|April 29, 2025
Insights into very elderly multiple myeloma treatment from Kansai Myeloma ForumYusuke Okayama, Teruhito Takakuwa, Yuji Shimura, et al.
Annals of Hematology|August 21, 2024
The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patientsYutaka Shimazu, Junya Kanda, Teruhito Takakuwa, et al.
Cancer Immunology, Immunotherapy : CII|May 17, 2024
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patientsYutaka Shimazu, Junya Kanda, Yoshiyuki Onda, et al.
Pageof 5